Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

Integral Molecular's MPA is the industry-leading technology for antibody specificity testing and is the only specificity platform under ... integrated into the drug discovery pipelines of over ...

On June 3, 2022, Sanyou Bio integrated the super-trillion-level molecule library and related cutting-edge technologies into a unified, comprehensive platform, named it "Sanyou Super-Trillion ...

comprehensive platform, named it "Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform (STAL)", and officially released it to the public. STAL was designed to integrate a variety of ...

forged through a decade of relentless effort — growing from weakness to strength — gradually building a vast and advanced technological system that paves a new path for drug discovery.

Zafrens is a pioneering biotech company transforming drug discovery Zafrens' breakthrough platform allows scientists ... to advanced cell therapies and antibody treatments. We're excited to ...

is a drug discovery company that utilizes generative AI, reverse immunology, and proprietary synthetic biology tech in its drug-creation platform to rapidly identify antibodies produced by super ...